Overview

Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population

Status:
Active, not recruiting

Trial end date:
2022-01-01

Target enrollment:

Participant gender:

Summary

The purpose of the research is to examine the outcomes of pediatric patients receiving Botulinum toxin type A (Botox ®) for the treatment of migraine. There is limited literature on the effectiveness of Botox ® in the treatment of chronic neurological pain in pediatric patients, specifically in the treatment of migraines.

Phase:

Phase 2

Details

Lead Sponsor:

University of California, Irvine

Collaborator:

American Society of Regional Anesthesia

Treatments:

abobotulinumtoxinA
Botulinum Toxins, Type A
onabotulinumtoxinA